Get started
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 ShPfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 ShPfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh

Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsBonds

Chart


Full chart

Key facts today


Pfizer's management has outlined a strategy aimed at driving growth post-2028, emphasizing cost improvements, targeted investments, and business development initiatives.
Pfizer settled with Texas for $41.5 million over claims of defrauding Medicaid regarding Quillivant XR. The lawsuit alleged manipulated testing results from 2012 to 2018. Pfizer denied wrongdoing.
Nona Biosciences has signed a license agreement with Pfizer, granting Pfizer global rights to the HCAB platform, with Nona Biosciences set to receive upfront and milestone payments.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪771.74 B‬ BRL
Dividend yield (indicated)
4.60%
Price to earnings Ratio (TTM)
14,091.67
Basic EPS (TTM)
0.00 BRL
Net income (FY)
‪43.24 B‬ BRL
Revenue (FY)
‪343.01 B‬ BRL
Shares float
—
Beta (1Y)
0.09

About Pfizer, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Albert Bourla
Website
pfizer.com
Headquarters
New York
Founded
1849
ISIN
BRPFIZBDR006
FIGI
BBG0017227L4
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Check out other big names from the same industry as PFIZ34.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


XS173899459
Pfizer Inc. 2.735% 15-JUN-2043
Yield to maturity
6.04%
Maturity date
Jun 15, 2043
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063
Yield to maturity
5.76%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053
Yield to maturity
5.64%
Maturity date
May 19, 2053
US717081ED1
Pfizer Inc. 4.125% 15-DEC-2046
Yield to maturity
5.53%
Maturity date
Dec 15, 2046
US717081EV1
Pfizer Inc. 4.0% 15-MAR-2049
Yield to maturity
5.53%
Maturity date
Mar 15, 2049
US717081FA6
Pfizer Inc. 2.7% 28-MAY-2050
Yield to maturity
5.50%
Maturity date
May 28, 2050
US717081EK5
Pfizer Inc. 4.2% 15-SEP-2048
Yield to maturity
5.49%
Maturity date
Sep 15, 2048
US717081DE0
Pfizer Inc. 4.3% 15-JUN-2043
Yield to maturity
5.46%
Maturity date
Jun 15, 2043
US717081DK6
Pfizer Inc. 4.4% 15-MAY-2044
Yield to maturity
5.34%
Maturity date
May 15, 2044
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043
Yield to maturity
5.28%
Maturity date
May 19, 2043
PFE4297191
Pfizer Inc. 5.6% 15-SEP-2040
Yield to maturity
5.21%
Maturity date
Sep 15, 2040

See all PFIZ34 bonds 

Sparks


Curated watchlists where PFIZ34 is featured.

See all sparks